Triple
T22421727
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Mitsubishi Tanabe Pharma |
E554263
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object |
Mitsubishi Tanabe Pharma Development America
Mitsubishi Tanabe Pharma Development America is a U.S.-based pharmaceutical research and development subsidiary of the Japanese company Mitsubishi Tanabe Pharma, focused on advancing new therapeutic drugs for global markets.
|
E554263
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Mitsubishi Tanabe Pharma Development America | Statement: [Mitsubishi Tanabe Pharma, hasSubsidiary, Mitsubishi Tanabe Pharma Development America]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Mitsubishi Tanabe Pharma Development America Context triple: [Mitsubishi Tanabe Pharma, hasSubsidiary, Mitsubishi Tanabe Pharma Development America]
-
A.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
B.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
C.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
D.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
E.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Mitsubishi Tanabe Pharma Development America Triple: [Mitsubishi Tanabe Pharma, hasSubsidiary, Mitsubishi Tanabe Pharma Development America]
Generated description
Mitsubishi Tanabe Pharma Development America is a U.S.-based pharmaceutical research and development subsidiary of the Japanese company Mitsubishi Tanabe Pharma, focused on advancing new therapeutic drugs for global markets.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Mitsubishi Tanabe Pharma Development America Target entity description: Mitsubishi Tanabe Pharma Development America is a U.S.-based pharmaceutical research and development subsidiary of the Japanese company Mitsubishi Tanabe Pharma, focused on advancing new therapeutic drugs for global markets.
-
A.
Mitsubishi Tanabe Pharma
chosen
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
B.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
C.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
D.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
E.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e4f2d0c819091aa3558ea2ee630 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f1594b08d88190bb61a30397d0ffa5 |
completed | April 29, 2026, 1:05 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a0b17d128b4819089480f643f6fbf5a |
completed | May 18, 2026, 1:44 p.m. |
| NEDg | Description generation | batch_6a0b188c406c81909f8d4bdd6d7a1819 |
completed | May 18, 2026, 1:47 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0b193a558c81909c8c8c8bd82f7bda |
completed | May 18, 2026, 1:50 p.m. |
Created at: April 16, 2026, 8:46 p.m.